Skip to main content
Signal8

Kosuri Sri

SEC insider (Form 3/4/5 filer). CIK 0002043887. Director at Ginkgo Bioworks Holdings, Inc. (DNA). 6 reported Form 4/5 transactions since Sep 2024; latest on Jun 11, 2026. Located in BOSTON, MA.

Companies Kosuri Sri has filed insider reports for

  • Ginkgo Bioworks Holdings, Inc. (DNA): Director
Kosuri Sri profile photo

Kosuri Sri

CIK: 0002043887

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)1 (16.7%)

Derivative conversions

Awards (A)5 (83.3%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Ginkgo Bioworks Holdings, Inc. logo
DNA

Ginkgo Bioworks Holdings, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (6 total)

  • Ginkgo Bioworks Holdings, Inc. logo
    DNA

    Ginkgo Bioworks Holdings, Inc.

    Jun 11, 2026
    Award

    Restricted Stock Units

    Direct
    25K shares-
  • Ginkgo Bioworks Holdings, Inc. logo
    DNA

    Ginkgo Bioworks Holdings, Inc.

    Jun 12, 2025
    Award

    Stock Option

    Direct
    34.4K shares-
  • Ginkgo Bioworks Holdings, Inc. logo
    DNA

    Ginkgo Bioworks Holdings, Inc.

    Jun 11, 2025
    Exercise
    Direct
    24.1K shares-
  • Ginkgo Bioworks Holdings, Inc. logo
    DNA

    Ginkgo Bioworks Holdings, Inc.

    Nov 6, 2024
    Award

    Stock Option

    Direct
    60.2K shares-
  • Ginkgo Bioworks Holdings, Inc. logo
    DNA

    Ginkgo Bioworks Holdings, Inc.

    Nov 6, 2024
    Award

    Stock Option

    Direct
    30.9K shares-
  • Ginkgo Bioworks Holdings, Inc. logo
    DNA

    Ginkgo Bioworks Holdings, Inc.

    Nov 6, 2024
    Award

    Restricted Stock Units

    Direct
    24.1K shares-

1-6 of 6